UBS, Switzerland's largest bank, is preparing for a legal battle with the U.S. Department of Justice. The DOJ is bringing civil charges against the bank for its sale of mortgage-backed securities just prior to the 2008 financial meltdown.
The DOJ has settled similar claims with Citigroup Inc., Deutsche Bank, JPMorgan Chase & Co., Credit Suisse Group, Morgan Stanley, Goldman Sachs, Bank of America Corp and Barclays Plc. Barclays reached a $2 billion settlement in March.
Separately, the government in France is asking a Paris court to fine UBS 1.6 billion euros or $1.8 billion for allegedly helping clients commit tax fraud. UBS is denying the charge that has stemmed from a six year investigation.
The 50-day moving average for UBS moved above the 200-day moving average on June 20, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on June 25, 2025. You may want to consider a long position or call options on UBS as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for UBS just turned positive on June 27, 2025. Looking at past instances where UBS's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .
UBS moved above its 50-day moving average on June 24, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UBS advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .
UBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 260 cases where UBS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UBS moved out of overbought territory on July 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 30, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. UBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.136) is normal, around the industry mean (0.958). UBS has a moderately low P/E Ratio (3.607) as compared to the industry average of (8.937). Projected Growth (PEG Ratio) (0.506) is also within normal values, averaging (2.643). UBS has a moderately low Dividend Yield (0.018) as compared to the industry average of (0.053). P/S Ratio (2.552) is also within normal values, averaging (2.460).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry MajorBanks